oxazoles has been researched along with eperezolid in 30 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 24 (80.00) | 18.2507 |
2000's | 6 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barbachyn, MR; Brickner, SJ; Ford, CW; Garmon, SA; Grega, KC; Hendges, SK; Hutchinson, DK; Manninen, PR; Toops, DS; Ulanowicz, DA; Zurenko, GE | 1 |
Barbachyn, MR; Brickner, SJ; Ford, CW; Hamel, JC; Hutchinson, DK; Moerman, JK; Stapert, D; Wilson, DM; Yancey, RJ | 1 |
Eliopoulos, GM; Gold, HS; Moellering, RC; Wennersten, CB | 1 |
Appelbaum, PC; Jacobs, MR; Spangler, SK | 1 |
Kaplan, SL; Lamberth, LB; Mason, EO | 1 |
Allison, JW; Barbachyn, MR; Brickner, SJ; Glickman, SE; Hutchinson, DK; Kilburn, JO; Schaadt, RD; Yagi, BH; Zurenko, GE | 1 |
Erwin, ME; Johnson, DM; Jones, RN | 1 |
Kaatz, GW; Seo, SM | 1 |
Drenning, SD; Mulazimoglu, L; Yu, VL | 1 |
Jorgensen, JH; McElmeel, ML; Trippy, CW | 1 |
Erwin, ME; Jones, RN; Worth, S | 1 |
Batts, DH; Daley-Yates, PT; Pawsey, SD; Schaadt, RD; Stalker, DJ; Zurenko, GE | 1 |
Lin, AH; Marotti, KR; Murray, RW; Vidmar, TJ | 1 |
Buysse, JM; Demyan, WF; Dunyak, DS; Lin, AH; Marotti, KR; Melchior, EP; Murray, RW; Shinabarger, DL; Swaney, SM | 1 |
Biedenbach, DJ; Jones, RN | 1 |
Aeschlimann, JR; Cappelletty, DM; Kaatz, GW; Moldovan, T; Rybak, MJ | 1 |
Marotti, KR; Murray, RW; Schaadt, RD; Zurenko, GE | 1 |
Adamski, JL; Allwine, DA; Barbachyn, MR; Brickner, SJ; Burton, PS; Conradi, RA; Ford, CW; Grega, KC; Hutchinson, DK; Jensen, RM; Klock, JL; Tucker, JA; Zurenko, GE | 1 |
Chase, S; Cynamon, MH; Klemens, SP; Sharpe, CA | 1 |
Barbadora, K; Green, M; Kearney, JA; Mason, EO; Wald, ER | 1 |
Fresnadillo, MJ; García-Rodríguez, JA; García-Sánchez, E; García-Sánchez, JE; Montes Martínez, I; Trujillano-Martín, I | 1 |
Hoppe, JE | 1 |
Eliopoulos, GM; Moellering, RC; Schülin, T; Thauvin-Eliopoulos, C | 1 |
Abdel-Rahman, SM; Kearns, GL | 1 |
Diekema, DI; Jones, RN | 1 |
Bowersock, TL; Ford, CW; Portis, ES; Prescott, JF; Robison, DA; Salmon, SA; Watts, JL | 1 |
Boggs, CM; Bush, K; Foleno, BD; Goldschmidt, RM; Hlasta, DJ; Weidner-Wells, MA; Wira, E | 1 |
Colleran, E; Cormican, M; Curtin, J; Fleming, G; Keelehan, J | 1 |
Kapadnis, PB; Lohray, BB; Lohray, VB; Pandya, P; Srivastava, BK | 1 |
Brieland, JK; Chosay, JG; Leach, KL; Nagiec, EE; Ross, DE; Swaney, SM; Wu, L | 1 |
2 review(s) available for oxazoles and eperezolid
Article | Year |
---|---|
An update on the oxazolidinone antibiotics.
Topics: Acetamides; Anti-Infective Agents; Drug Resistance, Microbial; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones | 1999 |
Oxazolidinones: a review.
Topics: Acetamides; Animals; Anti-Infective Agents; Humans; Linezolid; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones | 2000 |
1 trial(s) available for oxazoles and eperezolid
Article | Year |
---|---|
Serum inhibitory titers and serum bactericidal titers for human subjects receiving multiple doses of the antibacterial oxazolidinones eperezolid and linezolid.
Topics: Acetamides; Administration, Oral; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Linezolid; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Pneumococcal Infections; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae | 1997 |
27 other study(ies) available for oxazoles and eperezolid
Article | Year |
---|---|
Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant gram-positive bacterial infections.
Topics: Acetamides; Animals; Anti-Infective Agents; Dogs; Drug Resistance, Microbial; Drug Resistance, Multiple; Female; Linezolid; Magnetic Resonance Spectroscopy; Mass Spectrometry; Mice; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Rats | 1996 |
In vivo activities of U-100592 and U-100766, novel oxazolidinone antimicrobial agents, against experimental bacterial infections.
Topics: Acetamides; Administration, Oral; Animals; Anti-Bacterial Agents; Bacterial Infections; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Injections, Intravenous; Injections, Subcutaneous; Linezolid; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Staphylococcus aureus; Vancomycin | 1996 |
In vitro activities in new oxazolidinone antimicrobial agents against enterococci.
Topics: Acetamides; Anti-Bacterial Agents; Enterococcus; Linezolid; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones | 1996 |
Activities of RPR 106972 (a new oral streptogramin), cefditoren (a new oral cephalosporin), two new oxazolidinones (U-100592 and U-100766), and other oral and parenteral agents against 203 penicillin-susceptible and -resistant pneumococci.
Topics: Acetamides; Amino Acid Sequence; Anti-Bacterial Agents; Cephalosporins; Linezolid; Microbial Sensitivity Tests; Molecular Sequence Data; Oxazoles; Oxazolidinones; Penicillin Resistance; Streptococcus pneumoniae; Virginiamycin | 1996 |
In vitro activities of oxazolidinones U-100592 and U-100766 against penicillin-resistant and cephalosporin-resistant strains of Streptococcus pneumoniae.
Topics: Acetamides; Anti-Bacterial Agents; beta-Lactam Resistance; Ceftriaxone; Linezolid; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Penicillins; Streptococcus pneumoniae | 1996 |
In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents.
Topics: Acetamides; Anti-Bacterial Agents; Bacteria; Drug Resistance, Microbial; Linezolid; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Vancomycin | 1996 |
In vitro antimicrobial activities and spectra of U-100592 and U-100766, two novel fluorinated oxazolidinones.
Topics: Acetamides; Anti-Bacterial Agents; Bacteria; Bacteria, Anaerobic; Diffusion; Gram-Negative Bacteria; Gram-Positive Cocci; Linezolid; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones | 1996 |
In vitro activities of oxazolidinone compounds U100592 and U100766 against Staphylococcus aureus and Staphylococcus epidermidis.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Microbial; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Nafcillin; Oxazoles; Oxazolidinones; Penicillins; Staphylococcus aureus; Staphylococcus epidermidis; Time Factors; Vancomycin | 1996 |
In vitro activities of two novel oxazolidinones (U100592 and U100766), a new fluoroquinolone (trovafloxacin), and dalfopristin-quinupristin against Staphylococcus aureus and Staphylococcus epidermidis.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Synergism; Fluoroquinolones; Humans; Linezolid; Microbial Sensitivity Tests; Naphthyridines; Oxazoles; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Time Factors; Virginiamycin | 1996 |
In vitro activities of the oxazolidinone antibiotics U-100592 and U-100766 against Staphylococcus aureus and coagulase-negative Staphylococcus species.
Topics: Acetamides; Anti-Bacterial Agents; Coagulase; Colony Count, Microbial; Linezolid; Oxazoles; Oxazolidinones; Staphylococcus; Staphylococcus aureus | 1997 |
Quality control guidelines for amoxicillin, amoxicillin-clavulanate, azithromycin, piperacillin-tazobactam, roxithromycin, ticarcillin, ticarcillin-clavulanate, trovafloxacin (CP 99,219), U-100592, and U-100766 for various National Committee for Clinical
Topics: Acetamides; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Azithromycin; Clavulanic Acids; Fluoroquinolones; Humans; Linezolid; Microbial Sensitivity Tests; Naphthyridines; Oxazoles; Oxazolidinones; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Quality Control; Roxithromycin; Ticarcillin | 1996 |
The oxazolidinone eperezolid binds to the 50S ribosomal subunit and competes with binding of chloramphenicol and lincomycin.
Topics: Acetamides; Anti-Bacterial Agents; Chloramphenicol; Escherichia coli; Kinetics; Lincomycin; Oxazoles; Oxazolidinones; Puromycin; Ribosomes | 1997 |
Mechanism of action of oxazolidinones: effects of linezolid and eperezolid on translation reactions.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Proteins; Coliphages; Culture Media; Escherichia coli; Linezolid; Microbial Sensitivity Tests; N-Formylmethionine; Oxazoles; Oxazolidinones; Poly U; Polyribosomes; Protein Biosynthesis; Ribosomes; Transcription, Genetic | 1997 |
Disk diffusion test interpretive criteria and quality control recommendations for testing linezolid (U-100766) and eperezolid (U-100592) with commercially prepared reagents.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Resistance, Multiple; Evaluation Studies as Topic; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Indicators and Reagents; Linezolid; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Quality Control | 1997 |
Comparative in vitro activities and postantibiotic effects of the oxazolidinone compounds eperezolid (PNU-100592) and linezolid (PNU-100766) versus vancomycin against Staphylococcus aureus, coagulase-negative staphylococci, Enterococcus faecalis, and Ente
Topics: Acetamides; Anti-Bacterial Agents; Coagulase; Enterococcus faecalis; Enterococcus faecium; Humans; Linezolid; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Staphylococcus aureus; Vancomycin | 1998 |
Ribosomes from an oxazolidinone-resistant mutant confer resistance to eperezolid in a Staphylococcus aureus cell-free transcription-translation assay.
Topics: Acetamides; Anti-Bacterial Agents; Cell-Free System; Mutation; Oxazoles; Oxazolidinones; Protein Biosynthesis; Ribosomes; Staphylococcus aureus; Transcription, Genetic | 1998 |
Piperazinyl oxazolidinone antibacterial agents containing a pyridine, diazene, or triazene heteroaromatic ring.
Topics: Acetamides; Anti-Bacterial Agents; Caco-2 Cells; Enterococcus faecalis; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Permeability; Piperazines; Pyridines; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae; Structure-Activity Relationship; Triazenes | 1998 |
Activities of several novel oxazolidinones against Mycobacterium tuberculosis in a murine model.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Antitubercular Agents; Female; Linezolid; Mice; Mycobacterium tuberculosis; Oxazoles; Oxazolidinones; Tuberculosis | 1999 |
In vitro activities of the oxazolidinone compounds linezolid (PNU-100766) and eperzolid (PNU-100592) against middle ear isolates of Streptococcus pneumoniae.
Topics: Acetamides; Acute Disease; Anti-Bacterial Agents; Child; Clindamycin; Drug Resistance, Microbial; Erythromycin; Humans; Linezolid; Microbial Sensitivity Tests; Otitis Media; Oxazoles; Oxazolidinones; Penicillins; Pneumococcal Infections; Streptococcus pneumoniae | 1999 |
In vitro activities of five new antimicrobial agents against Brucella melitensis.
Topics: Acetamides; Anti-Bacterial Agents; Brucella melitensis; Humans; Linezolid; Microbial Sensitivity Tests; Mupirocin; Oxazoles; Oxazolidinones; Rifabutin; Virginiamycin | 1999 |
In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to the novel oxazolidinones eperezolid (PNU-100592) and linezolid (PNU-100766)
Topics: Acetamides; Anti-Bacterial Agents; Bordetella; Bordetella pertussis; Linezolid; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones | 1999 |
Activities of the oxazolidinones linezolid and eperezolid in experimental intra-abdominal abscess due to Enterococcus faecalis or vancomycin-resistant Enterococcus faecium.
Topics: Abdominal Abscess; Acetamides; Animals; Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Linezolid; Male; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Rats; Rats, Sprague-Dawley; Treatment Outcome; Vancomycin | 1999 |
MICs of oxazolidinones for Rhodococcus equi strains isolated from humans and animals.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Horses; Humans; Linezolid; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Rhodococcus equi | 2000 |
Novel piperidinyloxy oxazolidinone antimicrobial agents.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Piperidines; Staphylococcus aureus | 2001 |
Linezolid compared with eperezolid, vancomycin, and gentamicin in an in vitro model of antimicrobial lock therapy for Staphylococcus epidermidis central venous catheter-related biofilm infections.
Topics: Acetamides; Anti-Infective Agents; Biofilms; Catheterization, Central Venous; Catheters, Indwelling; Colony Count, Microbial; Gentamicins; Linezolid; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Sodium Chloride; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 2003 |
Novel tetrahydro-thieno pyridyl oxazolidinone: an antibacterial agent.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus faecalis; Linezolid; Methicillin; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Pyridines; Staphylococcus aureus; Structure-Activity Relationship; Vancomycin | 2004 |
Oxazolidinones inhibit cellular proliferation via inhibition of mitochondrial protein synthesis.
Topics: Acetamides; Animals; Blotting, Western; Cell Proliferation; Cells, Cultured; Flow Cytometry; Humans; In Vitro Techniques; K562 Cells; Linezolid; Mitochondria, Heart; Oxazoles; Oxazolidinones; Protein Synthesis Inhibitors; Rats; Structure-Activity Relationship | 2005 |